70899
Ni-NTA Buffer Kit
Synonym(s):
Buffer Kit for Ni-NTA, Ni-NTA Buffer
Sign In to View Organizational & Contract Pricing.
Select a Size
Change View
About This Item
NACRES:
NA.56
UNSPSC Code:
41106500
manufacturer/tradename
Novagen®
Quality Level
storage condition
OK to freeze
shipped in
ambient
storage temp.
10-30°C
General description
The Ni-NTA Buffer Kit provides a convenient set of buffers optimized for purification of His•Tag fusion proteins on Ni-NTA His•Bind Resin. These phosphate-buffered solutions differ from the Tris-based solutions used in the His•Bind Buffer Kit. Carefully prepared 4X concentrates are included for binding, washing and elution according to recommended protocols.
Other Notes
•2 × 125 ml4X Ni-NTA Bind Buffer
•125 ml4X Ni-NTA Wash Buffer
•50 ml4X Ni-NTA Elute Buffer
•125 ml4X Ni-NTA Wash Buffer
•50 ml4X Ni-NTA Elute Buffer
Legal Information
NOVAGEN is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Toxicity: Multiple Toxicity Values, refer to MSDS (O)
signalword
Danger
hcodes
Hazard Classifications
Eye Dam. 1 - Repr. 1B - Skin Corr. 1C
Storage Class
6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects
wgk
WGK 2
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Articles
YeastBuster™ Protein Extraction Reagent for Fast, Efficient Extraction of Proteins from Yeast
Shashi Gupta et al.
The Journal of biological chemistry, 289(12), 8706-8719 (2014-01-15)
Interleukin-6 (IL-6) is a pleiotropic cytokine that regulates immune and inflammatory responses, and its overproduction is a hallmark of inflammatory diseases. Inhibition of IL-6 signaling with the anti-IL-6 receptor antibody tocilizumab has provided some clinical benefit to patients; however, direct